Senseonics Holdings (Senseonics Holdings) Cash And Cash Equivalents : $75.71 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Cash And Cash Equivalents?

Senseonics Holdings's quarterly cash and cash equivalents increased from Jun. 2023 ($28.55 Mil) to Sep. 2023 ($55.76 Mil) and increased from Sep. 2023 ($55.76 Mil) to Dec. 2023 ($75.71 Mil).

Senseonics Holdings's annual cash and cash equivalents increased from Dec. 2021 ($33.46 Mil) to Dec. 2022 ($35.79 Mil) and increased from Dec. 2022 ($35.79 Mil) to Dec. 2023 ($75.71 Mil).

Senseonics Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Senseonics Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Cash And Cash Equivalents Chart

Senseonics Holdings Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

95.94

18.01

33.46

35.79

75.71

Senseonics Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															35.79	45.09	28.55	55.76	75.71

Senseonics Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Senseonics Holdings (AMEX:SENS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Senseonics Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Senseonics Holdings (Senseonics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

6L6:Germany 6L6:Germany

Address

20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005

Website

https://www.senseonics.com

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Executives

Sharon Larkin	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder	director	160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain	officer: VP Operations, Qual & Reg	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino	director	1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio	officer: VP Global Sales & Marketing	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow	director, officer: President & Chief Exec Officer	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman	officer: Chief Medical Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton	officer: GC & Corp. Development Advisor	VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco	director	ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince	director	20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876